Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy
Clinical trial NCT02286947 · COMPLETED
Trial details
- NCT number
- NCT02286947
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-04-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.